All News

Found 86 articles

• Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study

  6/30/2011

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease

  3/2/2011

• First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers

  5/21/2010

• GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc. Following FDA Approval, Agreement will Broaden Access to Cholesterol-Reducing Medicine

  11/27/2007

• Skyepharma PLC Responds To Allegations Made By North Atlantic Value Group

  3/3/2006

• Regence BlueCross BlueShield Of Oregon Announces Coverage Of FluMist In Response To The Shortage Of Injectable Flu Vaccine

  10/27/2004